In a new, rapidly growing company let's stick with the previous...

In a new, rapidly growing company let's stick with the previous quarter as it is most relevant to the current situation. Sales are at $201k (an increase of over 20 times in the 3 month period) against marketing costs of $230k (relatively stable). That growth is looking very promising and healthy if you ask me. As I have posted before, even a multiple of between 2 and 3 (who really knows, they pulled a 20 out of the bag) in this coming quarter puts sales up around $500k. 5 times from here by the year end puts it at min $1m. R&D costs were the big hit but the design and prototype of the sleep product is now completed with the program launching later this year. I would expect a reasonable reduction here which, in addition to sales growth, could negate the need to raise. This is without any potential deals, if there are any, on the way.

No-one here knows whether or not there is a CR on the way. It could go either way looking at the numbers and there is not enough information available to make a surefire assumption. If there is one, then so be it. The company put out a brilliant couple of ann's that would have exceeded almost any expectation. It's clear to anyone neutral to the situation that after a bit of a slow start early in the year, things are progressing well and at a rapid rate of knots. As much as downrampers with an agenda may want to convince otherwise, that revenue growth speaks for itself and the future for RNO now looks very promising.